NextPlat (NXPL) EBT Margin (2015 - 2026)
NextPlat's (NXPL) quarterly EBT Margin came in at 0.81% in Q2 2026, up 1247.0% year-over-year from 0.06% in Q2 2025, and up 92.97% quarter-over-quarter from 11.49% in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) EBT Margin (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported EBT Margin for 12 consecutive years, with 0.81% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin rose 1247.0% year-over-year to 0.81% in Q2 2026; TTM through Jun 2026 was 18.06%, a 572.0% increase from a year earlier, with the FY2025 full-year figure at 19.48%, up 1484.0% from the prior year.
- EBT Margin was 0.81% for Q2 2026 at NextPlat, up from 11.49% in the prior quarter.
- Over five years, EBT Margin peaked at 0.81% in Q2 2026 and troughed at 97.73% in Q4 2022.
- A 5-year average of 41.62% and a median of 31.72% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin soared 7315 bps in 2022 and slumped 3980 bps in 2023, its largest moves.
- Over 5 years, EBT Margin stood at 97.73% in 2022, then climbed by 9 bps to 88.84% in 2023, then surged by 82 bps to 16.42% in 2024, then plunged by 151 bps to 41.24% in 2025, then surged by 98 bps to 0.81% in 2026.
- The last three EBT Margin figures came in at 0.81% (Q2 2026), 11.49% (Q1 2026), and 41.24% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -10.99% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -1.70% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 6.85% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 8.92% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 12.20% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 13.94% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -121.92% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 20.96% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 11.27% |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | -0.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.81% |
| Mar 31, 2026 | -11.49% |
| Dec 31, 2025 | -41.24% |
| Sep 30, 2025 | -16.08% |
| Jun 30, 2025 | -13.28% |
| Mar 31, 2025 | -13.88% |
| Dec 31, 2024 | -16.42% |
| Sep 30, 2024 | -49.58% |
| Jun 30, 2024 | -63.12% |
| Mar 31, 2024 | -9.57% |
| Dec 31, 2023 | -88.84% |
| Sep 30, 2023 | -22.75% |
| Jun 30, 2023 | -97.46% |
| Mar 31, 2023 | -40.16% |
| Dec 31, 2022 | -97.73% |
| Sep 30, 2022 | -85.86% |
| Jun 30, 2022 | -57.67% |
| Mar 31, 2022 | -23.28% |
| Dec 31, 2021 | -170.88% |
| Sep 30, 2021 | -102.46% |